The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomics to select treatment for patients (pts) with metastatic cancer: Final analysis of Molecular Tumor Board (MTB) evaluations in the ROME trial.
 
Andrea Botticelli
Consulting or Advisory Role - Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Simone Scagnoli
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo; Lilly
 
Pierfranco Conte
Consulting or Advisory Role - Daiichi Sankyo; Gilead Sciences; Reveal Genomics
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech; Lilly; Novartis; Roche; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - her2DX patent
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Novartis; Pfizer
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Nordic Bioscience; Pierre Fabre; Roche
Speakers' Bureau - Merck; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER
 
Paolo Antonio Ascierto
Consulting or Advisory Role - 4SC; Anaveon; AstraZeneca; Bayer; Bio-AI Health; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Erasca, Inc; Idera; Immunocore; Italfarmaco; ITeos Therapeutics; Lunaphore Technologies; Medicenna; Merck Serono; Merck Sharp & Dohme; Nektar; Nouscom; Novartis; OncoSec; Pfizer; Philogen; Pierre Fabre; Regeneron; Replimune; Roche/Genentech; Sandoz; Sanofi; Seagen; Sun Pharma; Ultimovacs; ValoTx
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bio-AI Health; MSD Oncology; Pfizer; Pierre Fabre; Replimune
 
Federico Cappuzzo
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; bristol-myers; Lilly; MSD Oncology; Novocure; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Lilly; MSD Oncology; Novocure; pfizer; PharmaMar; Roche/Genentech; Sanofi; Takeda
Travel, Accommodations, Expenses - OSE Immunotherapeutics
 
Massimo Aglietta
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Roche
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Tesaro
 
Federica Mazzuca
Honoraria - Roche
Consulting or Advisory Role - Amgen; Merck; Roche
Speakers' Bureau - Roche
 
Ettore Capoluongo
Honoraria - AstraZeneca; GlaxoSmithKline; MSD
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; MSD; Roche
 
Giovanni Blandino
No Relationships to Disclose
 
Umberto Malapelle
Employment - Roche (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Diaceutics; GlaxoSmithKline; Lilly; Merck; MSD; Roche; Thermo Fisher Scientific
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Diaceutics; GlaxoSmithKline; Lilly; Merck; MSD; Roche; Thermo Fisher Scientific
 
Marianna Nuti
Research Funding - Incyte; Ipsen
 
Giulia D'Amati
Honoraria - MSD
Consulting or Advisory Role - MSD; Roche
Speakers' Bureau - MSD; Roche
 
Bruna Cerbelli
Honoraria - MSD
Consulting or Advisory Role - MSD
Speakers' Bureau - MSD; Roche
 
Giancarlo Pruneri
Honoraria - AstraZeneca; Exact Scienes/Genomic Health; Foundation One Inc; Novartis; Roche
Consulting or Advisory Role - ADS Biotec
Research Funding - Roche; Roche Molecular Diagnostics
 
Mauro Biffoni
No Relationships to Disclose
 
Giuseppe Giannini
No Relationships to Disclose
 
Francesco Cognetti
Honoraria - AstraZeneca; Exact Scienes/Genomic Health; GlaxoSmithKline
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - AstraZeneca; Exact Scienes/Genomic Health; GlaxoSmithKline; Lilly; Pfizer; Pierre Fabre; Roche
 
Giuseppe Curigliano
Leadership - ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech
 
Paolo Marchetti
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Eisai; Incyte; Merck; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Gentech; Incyte; Merck Serono; MSD; Novartis; Pierre Fabre; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)